Determinazione Dirigenziale del Responsabile della S.S.D. Formazione

Determinazione Dirigenziale del Responsabile della S.S.D. Formazione

N. del          

Oggetto: Aggiornamento Obbligatorio Dirigente Medico Xxxxxxxx Xxxxxxx

PDTD/2023/1399                                   

Pubblicata all’Albo Pretorio dell’Azienda a partire da            per 15 giorni consecutivi e posta a disposizione per la consultazione

S.C. Affari Generali - Xxxxxxx Xxxxxxxx

La presente Determinazione Dirigenziale prevede un impegno di spesa a carico dell’ARNAS X. Xxxxxx SI ☒ NO ☐

Il Responsabile della S.S.D. Formazione

Visto il D. LGS. n. 502/92 e successive modificazioni ed integrazioni;

Vista la Legge Regionale n. 24 del 11/09/2020 – Riforma del Sistema Sanitario Regionale e riorganizzazione sistematica delle norme in materia. Abrogazione della Legge Regionale n. 10 del 2006, della Legge Regionale n. 23 del 2014 e della Legge Regionale n. 17 del 2016 e di ulteriori norme di settore;

Visto il D. LGS. 50/2016;

Vista la Deliberazione n. 1811 del 07/08/2019, con la quale il Commissario Straordinario ha conferito delega al Responsabile della S.S.D. Formazione alla predisposizione delle Determinazioni Dirigenziali;

Vista la Deliberazione n. 72 del 20/01/2023, con la quale è stato approvato il nuovo Atto Aziendale dell’ARNAS X. Xxxxxx;

Dato Atto che, al fine di garantire la regolare attività formativa, si rende necessario procedere all’autorizzazione degli aggiornamenti fuori sede come da precedente Organigramma;

Vista la comunicazione Protocollo n. 13 del 04/09/2023, con la quale il Direttore della S.C. Chirurgia Senologica ha fatto richiesta di comando obbligatorio per aggiornamento in favore del Xxxx. Xxxxxxxx Xxxxxxx;

Visto il parere favorevole del Direttore del Dipartimento Oncologico Chirurgico;

Ritenuto di dover autorizzare la partecipazione del Xxxx. Xxxxxxxx Xxxxxxx all’evento formativo dal titolo: “MBN 2023 Xxxxxxxxxxx Breast Meeting”, che si terrà a Milano dal 13/12/2023 al 16/12/2023, per una spesa complessiva presunta di € 1.781,36 (millesettecentoottantuno/36 euro) come da documentazione agli atti di questa S.S.D.;

%

segue Determinazione n.   del       

Considerato che tale spesa ricadrà sul Fondo Dirigenza Medica per l’aggiornamento obbligatorio - Dipartimento Chirurgico - Fondi di Struttura 2023, del quale risulta verificata la copertura finanziaria, e che la liquidazione dei costi sostenuti dovrà essere effettuata previa trasmissione ai competenti Uffici, a cura del dipendente, di una relazione sull’aggiornamento, dell’attestato di partecipazione all’evento formativo e della documentazione giustificativa;

DETERMINA

Per le motivazioni espresse in premessa, di:

1. Autorizzare la partecipazione del Xxxx. Xxxxxxxx Xxxxxxx all’evento formativo dal titolo: “MBN 2023 Xxxxxxxxxxx Breast Meeting”, che si terrà a Milano dal 13/12/2023 al 16/12/2023;

2. Dare atto che la spesa complessiva presunta di € 1.781,36 (millesettecentoottantuno/36 euro) ricadrà sul Fondo Dirigenza Medica per l’aggiornamento obbligatorio - Dipartimento Chirurgico - Fondi di Struttura 2023, del quale risulta verificata la copertura finanziaria;

3. Autorizzare la liquidazione della quota di iscrizione previa ricezione della fattura da parte dell’Ente organizzatore;

4. Disporre che la liquidazione dei costi sostenuti dovrà essere effettuata previa trasmissione ai competenti Uffici, a cura del dipendente, di una relazione sull’aggiornamento, dell’attestato di partecipazione all’evento formativo e della documentazione giustificativa;

5. Trasmettere la presente Determinazione al Direttore della S.C. Risorse Umane e Relazioni Sindacali.

Il Responsabile della S.S.D. Formazione Dott.ssa Xxxxx Xxxxxx

XXXXXX XXXXX

Firmato digitalmente da XXXXXX

XXXXX

Data: 2023.09.19 13:57:42 +02'00'

Estensore

XXXX

Firmato digitalmente da

XXXXXX Data: 2023.09.11

XXXX XXXXXX

13:49:05 +02'00'

13th December

14.00

15.15-15.30

15.30–18.30

REGISTRATION OPENING

VIDEO TEACHING SESSIONS: CASE SERIES

Moderator: X.X. Xxxx - A. Rancati

Case series based on pre-op. patients characteristics, oncological features, patient’s wishes, imaging; five KOL will introduce the last surgical procedures, tip and tricks, new devices and material and how to use them to improve the final outcome in xxxxxxxxxxx breast surgery.

Each session will start with multiple choice questions in an interactive way with the attendees in order to investigate the attendees preferences before and after the video teaching session.

TOPICS:

Breast Conservative Surgery and Breast Reshaping

Y. Masannat - A. Karakatsanis - C. Urban - X. Xxxxxxxx

Xxxxxxxxxxx Breast Surgery and the Role of Fluorescence

S. Folli - A. Rancati - X. Xxxx - X. Xxxxxx

Sparing Mastectomies and DTI

X. Xxxxxxxxxx - X. Xxxxxxxx - X. Casella - R. De Vita - X. Xxxx

Autologous tissue – Fat grafting – Perforator flaps – Microsurgery

X. Xxxxxxxxxx - X. Xxxxxxx - C. Angrigiani

Two Stage - Revision Surgery

X. Xxxxxxx - X. De Vita - A. Rancati - M. Hamdi - X. Xxxxxxx

MBN 2O23 XXXXXXXXXXX BREAST MEETING

MASTERS & PROMISES

13-16 December

08.00 09.00-09.10	REGISTRATION OPENING	12.35–12.55	MASTERS AND PROMISES Post-NACT Axillary management - X. Xxxxxx / X. Xxxxxxxx
09.15–09.35	OPENING LECTURE	12.55-13.55	LUNCH
09.35–10.50	Half century of Xxxxxxxxxxx Breast Surgery: my personal journey M.B. Xxxx Impact of Fluorescence in Xxxxxxxxxxx Breast Surgery (10’ each) Principles og ICG Technology Imaging decision making with fluorescent technology - X. Xxxxxx (Web) SLN & ICG - F. Dip Importance of perfusion in breast reconstruction - S. Folli Free flaps & ICG - C. Angrigiani Importance of breast perforators mapping in xxxxxxxxxxx surgery - A. Rancati	14.00-15.00 15.00–15.20	Workshop - Primary systemic therapies and surgery (10’ each) What is new in primary systemic therapies for breast cancer - X. Xxxxxxxxxxxx Breast surgery following primary systemic therapies - X. Xxxxx XXXXXXXXX trial: omitting RT in pCR patients - F. Xxx Xxxxxxxxxx Adjuvant therapies following primary systemic therapies - C. De Angelis Radiotherapy following primary systemic therapies - O. Kaidar Person Discussion led by X. Xxxxxxxxxxxx - X. Xxxxxxxx (10’) ONGOING TRIALS TAXIS trial/OMA trial/ICARO trial - X. Xxxxx - X. Xxxxxxxx (10’ each)
10.50–11.05	Discussion led by X. Xxxxxxxx - X.X. Xxxx (15’) KEYNOTE LECTURE	15.10–16.00	Workshop - Breast cancer treatment in BRCA mutation carriers (10’ each) In favour of breast conserving surgery - Y. Masannat Against breast conserving surgery - X. Xxxxx
11.05-12.35	How to plan a conservative mastectomy to reduce complications X. Xxxxx Conservative mastectomies and DTI-IBBR : How I do it (10’ each)		Systemic therapies in BRCA mutation carriers - C. De Angelis RT in BRCA mutated patients I. Meattini Risk reduction mastectomies (focus on in patients with a previous history of breast cancer) R. De Vita
	“How I do it” includes: pre-operative description, pre-operative marking, surgical tricks (supported by micro videos). Final results (post op at three and six months)	16.00–16.50	Workshop - Risk reduction in BRCA mutation carriers (10’ each)
	Nipple-sparing mastectomy - A. Rancati		What is new in the genetic assessment of women with familiar history for breast cancer A. De Nicolo
	Skin sparing mastectomy - A. Rancati Skin reducing mastectomy - E. Xxxxxxxx How to choose the surgical procedure in relation to the anatomy of the breast - A. Rancati Two-stage technique - X. Xxxxxxx DTI dual plane ADM-assisted - X. Xxxxxxxxxx	16.50-17.00	Risk reduction mastectomies - X. Xxxxxx Non Surgical Risk Reduction - X. Xxxxxxxxxxxx Follow-up following risk reducing surgery - X. Xxxxxxxxxxx Discussion
	Prepectoral breast reconstruction - R. De Vita Prepectoral breast reconstruction - X. Xxxxxxxx	17.00-17.20	COFFEE BREAK
	Open Discussion led by X. Xxxxxxxx - X. Xxxx - A. Xxxxxxx (20’) Panelists: All sessions presenters		GUEST LECTURE De-escalation of surgery - X. Xxxxxx

14th December

17.20- 18.20	INDUSTRY SPONSORED SESSION ADMs vs Synthetic meshes for breast reconstruction (video session on surgery technique and explanation) (10’ each)	08.00–08.30	BREAKFAST WORKSHOP The symmetrization of the contralateral breast in relation to the type of breast reconstruction for a long-lasting result. My personal view X. Xxxxxxx - M. Hamdi - X. Xxxxxxxxxx
	Discussion led by C. Urban - X. Xxxxxxxx - X. Xxxxxxx
18.20–19.00	INDUSTRY SPONSORED SESSION	08.30 - 08.45	KEYNOTE LECTURE Management of loco-regional recurrence - I. Xxxxx
	Two-stage: my preferred device (10’ each)
		08.45-09.25	Xxxxxxxxxxx Breast Conserving Surgery : How I do it (10’ each)
	Open Discussion led by X.X. Xxxx - A. Rancati		Minimal reshaping - Y. Masannat
	Panelists: All sessions presenters		Maximal reshaping and Bilateral mammoplasty - A. Karakatsanis
			BCS in small breast and implants - C. Urban
19.00	WELCOME COCKTAIL
			Open Discussion led by X. Xxxxxxxx
			Panelists: All session presenters
		09.25-10.25	Video teaching on live models. Xxxxxxxxxxx Breast Surgery
			A. Rancati - R. De Vita - X. Xxxxxxxxxx - E. Xxxxxxxx - X. Hamdi - X. Xxxxxx
			Open Discussion led by X.X. Xxxx - X. Masannat - X. Xxxxxxxx
		10.25-10.45	MASTERS AND PROMISES
			Xxxxxxxxxxx breast conserving surgery - F. Xx Xxxxx
		10.45-11.25	Workshop- Special topics on OBS (10’ each)
			Techniques for TAD procedure after neoadjuvant treatment - I. Xxxxx
			Perforator flaps: PERDITA Survey - A. Karakatsanis
			Immediate Fat grafting and breast conservation - E. Xxxxxxxx (web)
			Discussion
		11.25-12.15	Workshop - Management of complications in xxxxxxxxxxx breast surgery (10’ each)
			How to manage complications in implant-based breast reconstruction - X. Xxxxxxxxxx
			How to manage complications in xxxxxxxxxxx breast conserving surgery - C. Urban
			How to manage complications in autologous tissue -based breast reconstruction - X. Xxxxxxxxxx
			NPWT in the prevention of complications in OPBS - X. Xxxxxxxx
			Discussion

14th December

15th December

12.15-13.00	KEYNOTE LECTURES (15’ each) The use of intraoperative US in assessing margins - I. Xxxxx Breast Reconstruction after NST: which is the best approach in implannt based breast recon- struction? - E. Xxxxxxxx From two stage to Bioengineering Breast Reconstruction - X. Xxxxxxx	17.00-18.00	Impact of fluorescence in xxxxxxxxxxx breast surgery Fluorescent nerve visualization - F. Dip Can we preserve breast sensitivity after mastectomy? - A. Rancati Barriers & adoption - X. Xxxxxxxxx (web) Flourescence & lymphedema - X. Xxxx
13.00-14.00	LUNCH		Where are we going - M. Xxxxx
14.00–14.50	Special session - Surgeons vs Radiation Oncologists (10’ each speaker)		Discussion led by X.X. Xxxx - A. Rancati
	Breast reconstruction in the RT setting - X. Xxxxxxxxxx - X. Xxxxxxxxx Breast conserving surgery for multiple ipsilateral cancers - X. Xxxxxx - O. Kaidar	18.00-19.00	INDUSTRY SPONSORED SESSION DTI and Contralateral Reshaping: my preferred permanent implant and surgical
	Discussion led by O. Kaidar Person - X. Xxxxx		procedure
14.50-15.40	Workshop - ADMs (10’ each)		Discussion led by X.X. Xxxx - A. Rancati - X. Xxxxx
	Prepectoral breast reconstruction: do we need an ADM? - C. Urban
	The use of human-derived ADMs - X. Xxxxxxxx The role of ADMs in dual plane DTI IBBR - X. Xxxxx	19.00	END OF WORK
	ADMs and expanders - X. Xxxxxxx
	Discussion led by A. Rancati
15.40–16.20	Workshop - Breast Imaging and Xxxxxxxxxxx Breast Surgery (10’ each)
	BTCC standardization of measurements at digital mammography - X. Xxxxxxx
	Decision-Making for conservative mastectomies and pre-operative imaging - A. Rancati
	Pre-operative imaging and surgical outcomes - X. Xxxxxxxxxx
	Open Discussion led by X. Xxxxxxxx - X. Xxxxx
	Panelists: all session presenters
16.20 -16.40	GUEST LECTURE
	Axillary management in upfront surgery for breast cancer in the XXI Century - X. Xxxxxx
16.40-17.00	MASTERS AND PROMISES
	Radiotherapy and Immune Therapy - X. Xxxxxxxxx

15th December

08.00–08.30	HOT TOPICS (10’ each)	12.15–12.35	SPECIAL LECTURE
	Artificial Intelligence in Xxxxxxxxxxx Breast Surgery: Myths or reality? - X. Xxxxxxxx NAC Reconstruction or reshaping: what’s new? - X. Xxxxxxxxxxx		Ethics in xxxxxxxxxxx breast surgery - X. Xxxxxxxxx
	Light implant in IBBR - M. Hamdi	12.35-13.25	Special sessions - Ideas and Innovations - Surgeons/Engineers (12’ each)
	My decision algorithm in breast reconstruction - X. Xxxxxxxxxx		Breast Cancer Metaverse - X. Xxxxxxx/ Engineer
	The gold balance and the cyrcle of remodeling: degradation and regeneration in breast surgery		Virtual reality and breast surgery - F. Reyal/ Engineer
	D. Varvaras		In silico trials - X. Xxxxxxxx - X. Xxxxxxxxxx
08.50–09.50	Autologous-tissue based breast reconstruction: How I do it (10’ each)		Discussion (15’)
	DIEP flap - X. Xxxxxxxxxx
	LD Flap - X. Xxxxxxx	13.25 – 14.15	Special topics (10’ each)
	TRAMF - E. Xxxxxxxx		The superficial margin in mastectomies - a margin of concern? - T. Tramm
	Perforator flaps (web) - C. Angrigiani		Assessing the superficial margin with intraop ultrasound - I. Xxxxx / A. Esgueva
			Surgery of the primary breast tumor in the metastatic setting - X. Xxxxxx
	Discussion led by X. Xxxxxxxxxx - M. Hamdi		Management of DCIS - F. Xxx Xxxxxxxxxx
	Panelists: all session presenters
			Discussion
09.50-10.20	RT and Breast Reconstruction: Have the new techniques improved tissue and breast
	implants damages and therefore improved reconstructive results?	14.15	CLOSURE & REMARKS
	The point of view of the radiologist - I. Meattini		Farewell Lunch
	The point of view of the senologist - X. Xxxxxx
	The point of view of the plastic surgeon - X. Xxxx
10.20-11.05	How I do it: Teaching on live models - Implant based breast reconstruction
	(two-stage/dual plane/pre pec/ADM/Synthetic) - A. Xxxxxxx - X. Xxxxxxxxxx - X. Xxxxxxxxxx
	X. Xxxxxxx - X. Xxxxx - D. Casella - X. Xxxx
	Open Discussion led by X.X. Xxxx - X. Rancati - X. Xxxxx
	Panelists: All session presenters
11.05 – 11.45	Special session - Implant-based vs Autologous tissue-based breast reconstruction
	(10’ each speaker)
	Xxxxxxxx Review Implant-based vs. Autologous tissue - X. Xxxxx
	X. Xxxxxxxxxx VS X. Xxxxxxx
	Xxxxxxxxxx led by X. Xxxxx
11.45–12.15	KEYNOTE LECTURE
	Fat Grafting: what’s new - X. Xxxxxxx

16th December